Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2022-10-17

FDA Approved: FUROSEMIDE — Original Application (Rising Pharma Holdings, Inc.)

View source ↗

Summary

The FDA approved Rising Pharma Holdings, Inc.'s original ANDA for furosemide, authorizing a generic version of this diuretic.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • FUROSEMIDE (Furosemide)

Snippet

ORIG AP for FUROSEMIDE (FUROSEMIDE)